Midlife Hormone Therapy Linked to Lower Dementia Risk in Major Study

A large UK Biobank study suggests that women who begin common hormone replacement therapy between ages 46 and 56 may face a 23% lower risk of developing Alzheimer's disease and dementia.

2 Sept, 19:10 — 2 Sept, 19:10

Post Share

Sources

Showing 1 of 1 sources

Fox NewsMixed8h ago

Women who start common hormone therapy in their 50s may have 23% lower dementia risk

Hormone replacement therapy started between ages 46 and 56 was tied to lower Alzheimer's and dementia risk, a major new UK Biobank study suggests.

Read full article →

Midlife Hormone Therapy Linked to Lower Dementia Risk in Major Study

Sources

Women who start common hormone therapy in their 50s may have 23% lower dementia risk

Related Stories

Singer Lionel Richie Discharged After Cardiac Evaluation

Study suggests widely used sweetener may have serious health risks

Ebola Death Toll Surpasses 3,000 in Democratic Republic of Congo

Teva Reports Positive Mid-Stage Trial Results for Celiac Disease Drug